trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Diabetic individuals have an increased risk of cancer compared to non-diabetic individuals.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that diabetic individuals have an increased risk of cancer compared to non-diabetic individuals?

Yes. Extensive epidemiological and mechanistic evidence indicates that diabetic individuals face an increased risk of developing several types of cancer, mediated by factors such as hyperinsulinemia, hyperglycemia, and chronic inflammation.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently points to an elevated cancer risk among diabetic individuals across multiple cancer sites (such as breast, pancreas, liver, and colon), supported by both epidemiological studies and shared molecular mechanisms like hyperinsulinemia and chronic inflammation. Consequently, the claim is well-supported by the evidence.

Evidence for · 7
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
2012
Reviews epidemiological evidence showing an increased incidence of several cancers, such as pancreatic, hepatic, and colorectal, among diabetes patients.
Get citation
Shikata, K., Ninomiya, T., & Kiyohara, Y. (2012). Diabetes mellitus and cancer risk: Review of the epidemiological evidence. doi.org. https://doi.org/10.1111/cas.12043

See more details
More for · 6
Associations of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios with cancer incidence in type 2 diabetes.
2026
Observes that cancer incidence is positively associated with inflammatory markers in type 2 diabetes mellitus patients.
Get citation
Y, M., M, I., Y, H., & M, F. (2026). Associations of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios with cancer incidence in type 2 diabetes.. doi.org. https://doi.org/10.1016/j.clnesp.2026.103419

Evaluation of cancer frequency and characteristics in patients with type 2 diabetes mellitus in primary health care: a descriptive cross-sectional study.
2026
Reports a high prevalence of cancer among adult type 2 diabetes mellitus patients in a primary care setting.
Get citation
Ü, S. Ü., YD, A., ME, D., M, K., A, K., ÖD, Ö., & B, Ö. (2026). Evaluation of cancer frequency and characteristics in patients with type 2 diabetes mellitus in primary health care: a descriptive cross-sectional study.. doi.org. https://doi.org/10.1017/s1463423626101935

The Impact of Diabetes on Breast Cancer Development in Women: An Integrative Review.
2026
Indicates that diabetes is associated with a modest elevation in breast cancer risk and poorer clinical outcomes.
Get citation
I, J., M, H., I, H., & FT, Z. (2026). The Impact of Diabetes on Breast Cancer Development in Women: An Integrative Review.. doi.org. https://doi.org/10.1002/edm2.70276

Gestational diabetes mellitus and long-term cancer risk: a narrative review of epidemiological and mechanistic evidence.
2026
Highlights emergent epidemiological evidence suggesting a link between gestational diabetes mellitus and increased long-term cancer risk.
Get citation
AL, A. L. (2026). Gestational diabetes mellitus and long-term cancer risk: a narrative review of epidemiological and mechanistic evidence.. doi.org. https://doi.org/10.1515/jbcpp-2026-0136

Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms.
2026
Synthesizes evidence showing that diabetes significantly increases the risk of multiple cancer types through mechanisms like hyperinsulinemia and hyperglycemia.
Get citation
Y, H., S, J., & S, L. (2026). Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms.. doi.org. https://doi.org/10.1016/j.bbrc.2026.154205

Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets.
2026
Demonstrates through meta-analysis that diabetes is significantly associated with an increased risk of pancreatic ductal adenocarcinoma.
Get citation
J, Z., Z, L., K, H., J, Y., & MO, K. (2026). Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets.. doi.org. https://doi.org/10.7150/jca.134528

What does the evidence say?

The retrieved literature consistently points to an elevated cancer risk among diabetic individuals across multiple cancer sites (such as breast, pancreas, liver, and colon), supported by both epidemiological studies and shared molecular mechanisms like hyperinsulinemia and chronic inflammation. Consequently, the claim is well-supported by the evidence.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work